Marvell Technology Group Ltd (MRVL) — chart, structure and Closelook read

Pick a ticker to load its detail page.

About Marvell Technology Group Ltd

Marvell Technology Group Ltd (MRVL) trades on US exchanges. It is a constituent of Rubin Build-Out 100, sitting in Layer 5 of the build-out stack.

The print record

8 of 10 EPS beats and 9 of 10 revenue beats across the covered prints, with three-day reactions splitting 4 up · 2 flat · 4 down (as of the 2026-08-28 card). Eight EPS beats and nine revenue beats in ten — processed into a 4-2-4 split with almost nothing in the middle: the ten windows span −27.1% to +23.3%, and eight of ten landed beyond ±6%. Coming in, the market had paid three straight — +6.5%, +23.3%, +10.4% — the only payment streak on the card. Last night’s record quarter was sold −7.8% after hours; Tuesday’s close decides whether the streak breaks.

The full Marvell Technology Group Ltd print-record card →

closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

FAQ · from the current data · as of 2026-08-29

Quick answers

What is Marvell Technology Group Ltd (MRVL)?

Marvell Technology Group Ltd trades as MRVL on the US exchange (US) in the Closelook research universe, as of the registry build of 2026-08-29.

Is MRVL in a Closelook index?

Yes — Marvell Technology Group Ltd is a constituent of Rubin Build-Out 100, as of 2026-08-29.

What is Marvell Technology Group Ltd's earnings print record?

Across the 10 prints Closelook covers, Marvell Technology Group Ltd beat EPS estimates 8 times and revenue estimates 9 times; the three-day reactions split 4 up, 2 flat and 4 down (moves beyond ±3%), as of the 2026-08-28 card. The full print-record card carries the per-print history.

What does this page show?

A live price chart with SMA overlays and drawing tools for MRVL, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Related in the Closelook universe